country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-14361

Copy Link Print Information

MK-4965

MK-4965 is a nonnucleoside reverse transcriptase inhibitor (NNRTI). MK-4965 displays excellent activities against not only HIV-1 wild-type (WT) virus but also against a broad panel of NNRTI-resistant viruses and can be used for the research of HIV-1 infection.

For research use only. We do not sell to patients.

CAS No.: 920035-77-4
Formula: C₂₀H₁₃Cl₂N₅O₂
Molecular Weight:426.26

Storage:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (268 KB)

MK-4965 Chemical Structure

CAS No.: 920035-77-4

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- IC₅₀ & Target
- Cellular Effect
Chemical Information
Protocols (1)
Purity & Documentation
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

Description

IC₅₀ & Target

IC50: 0.23 nM (WT), 0.39 nM (Y181C), 0.40 nM (K103N)^[1]

All HIV Isoforms :

Cellular Effect

Cell Line	Type	Value	Description	References
HL-60	EC₅₀	>3 μM Compound: MK-4965	Cytotoxicity against human HL60 cells after 24 to 72 hrs by alamar blue assay Cytotoxicity against human HL60 cells after 24 to 72 hrs by alamar blue assay	[PMID: 19289522]
Macrophage	EC₅₀	>3 μM Compound: MK-4965	Cytotoxicity against activated human macrophage after 24 to 72 hrs by alamar blue assay Cytotoxicity against activated human macrophage after 24 to 72 hrs by alamar blue assay	[PMID: 19289522]
Macrophage	EC₅₀	>3 μM Compound: MK-4965	Cytotoxicity against stationary-phase human macrophage after 24 to 72 hrs by alamar blue assay Cytotoxicity against stationary-phase human macrophage after 24 to 72 hrs by alamar blue assay	[PMID: 19289522]
Monocyte	EC₅₀	>3 μM Compound: MK-4965	Cytotoxicity against activated human monocyte after 24 to 72 hrs by alamar blue assay Cytotoxicity against activated human monocyte after 24 to 72 hrs by alamar blue assay	[PMID: 19289522]
Monocyte	EC₅₀	>3 μM Compound: MK-4965	Cytotoxicity against stationary-phase human monocyte after 24 to 72 hrs by alamar blue assay Cytotoxicity against stationary-phase human monocyte after 24 to 72 hrs by alamar blue assay	[PMID: 19289522]
MT4	EC₅₀	>3 μM Compound: MK-4965	Cytotoxicity against human MT4 cells after 24 to 72 hrs by alamar blue assay Cytotoxicity against human MT4 cells after 24 to 72 hrs by alamar blue assay	[PMID: 19289522]
PBMC	EC₅₀	>3 μM Compound: MK-4965	Cytotoxicity against activated human PBMC after 24 to 72 hrs by alamar blue assay Cytotoxicity against activated human PBMC after 24 to 72 hrs by alamar blue assay	[PMID: 19289522]
PBMC	EC₅₀	>3 μM Compound: MK-4965	Cytotoxicity against stationary-phase human PBMC after 24 to 72 hrs by alamar blue assay Cytotoxicity against stationary-phase human PBMC after 24 to 72 hrs by alamar blue assay	[PMID: 19289522]
SUP-T1	EC₅₀	>3 μM Compound: MK-4965	Cytotoxicity against human SupT1 cells after 24 to 72 hrs by alamar blue assay Cytotoxicity against human SupT1 cells after 24 to 72 hrs by alamar blue assay	[PMID: 19289522]
T-cell	EC₅₀	>3 μM Compound: MK-4965	Cytotoxicity against activated human CD4+ T cells after 24 to 72 hrs by alamar blue assay Cytotoxicity against activated human CD4+ T cells after 24 to 72 hrs by alamar blue assay	[PMID: 19289522]
T-cell	EC₅₀	>3 μM Compound: MK-4965	Cytotoxicity against stationary-phase human CD4+ T cells after 24 to 72 hrs by alamar blue assay Cytotoxicity against stationary-phase human CD4+ T cells after 24 to 72 hrs by alamar blue assay	[PMID: 19289522]

Chemical Information

CAS No. 920035-77-4
Molecular Weight 426.26
Formula C₂₀H₁₃Cl₂N₅O₂
SMILES

N#CC1=CC(Cl)=CC(OC2=CC(OCC3=NNC4=NC(N)=CC=C43)=CC=C2Cl)=C1
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Protocols

All Signal Pathway Related

Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (268 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Lai MT, et al. Antiviral activity of MK-4965, a novel nonnucleoside reverse transcriptase inhibitor. Antimicrob Agents Chemother. 2009 Jun;53(6):2424-31. [Content Brief]

Calculators

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Get Quote In-stock

Other size

Get Quote